Anil Bajnath, MD

Anil Bajnath, MD Where Precision Medicine meets Longevity! Join our journey to better, longer living!

Follow for expert insights, biohacking tips, and multiomic breakthroughs that empower you to become the 'CEO of Your Health' and optimize your life.

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_ultra-processed-foods-upfs-are-no-longer-activi...
08/29/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_ultra-processed-foods-upfs-are-no-longer-activity-7367172947800764417-XpVu?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

Ultra-processed foods (UPFs) are no longer just a nutrition debate — they are emerging as endocrine disruptors in plain sight. A new randomized controlled trial published in Cell Metabolism dissects the direct effects of UPF consumption in healthy young men. By matching caloric intake between UPF ...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-aml-immunooncology-activity-7...
08/28/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-aml-immunooncology-activity-7366892120491696130-dGMq?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

One of the most complex challenges in leukemia treatment is not only clonal evolution — but lineage plasticity. A new Nature Communications study dissects lineage-switched acute myeloid leukemia (LS AML) with KMT2A rearrangement, a rare but devastating transformation often triggered after CD19-dir...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_calorierestriction-glycomics-biologicalage-acti...
08/27/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_calorierestriction-glycomics-biologicalage-activity-7366456441030848514-0JaX?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

Calorie Restriction and Biological Age: New Glycomic Insights How much can lifestyle interventions truly modulate the biology of aging? A recent pilot study from the CALERIE Phase 2 trial suggests that sustained calorie restriction (CR) does more than reduce weight — it may reshape the glycomic ar...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_longevitymedicine-precisionmedicine-agingbiomar...
08/26/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_longevitymedicine-precisionmedicine-agingbiomarkers-activity-7366079710709071872-E61B?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

Calorie Restriction, Glycans, and the Biology of Aging: Insights from a 2-Year Pilot Study Calorie restriction (CR) has long been a cornerstone of longevity research, consistently linked with extended lifespan in model organisms. But the question remains: how does CR impact the molecular hallmarks o...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_exposome-genomics-precisionmedicine-activity-73...
08/21/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_exposome-genomics-precisionmedicine-activity-7364270395262156800-Jwgo?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

Beyond the Genome: Why the Future of Precision Medicine Must Embrace the Exposome Genomics has transformed medicine, but genetics alone does not dictate destiny. The exposome — the totality of environmental, dietary, occupational, and lifestyle exposures across a lifetime — is the missing half. ...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_tumour-resident-bacteria-harnessing-microbes-ac...
08/20/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_tumour-resident-bacteria-harnessing-microbes-activity-7363906548315656192-5qpy?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

Tumour-Resident Bacteria: Harnessing Microbes as Precision Oncologic Therapies One of the most compelling shifts in modern oncology is the recognition that the tumor microenvironment is not just a bystander — it is a therapeutic target. A recent Nature Biomedical Engineering article (August 2025) ...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-nutritionscience-omega3-activ...
08/19/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-nutritionscience-omega3-activity-7363548120107884545-6y2e?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

Omega-3 Fatty Acid Status: A Global Snapshot of Health and Risk Omega-3 fatty acids—particularly EPA and DHA—are well known for their cardiovascular, neurological, and anti-inflammatory benefits. But how do population-level patterns look worldwide? A new study analyzing over 500,000 dried blood ...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_antimicrobialresistance-precisionmedicine-activ...
08/18/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_antimicrobialresistance-precisionmedicine-activity-7363193316290502656-ZFXP?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

Deep Learning and the Hidden Antibiotics of Archaea: A New Frontier in the Fight Against AMR Antimicrobial resistance (AMR) is often called the silent pandemic. It is projected to cause 10 million deaths annually by 2050 if new therapies are not developed. Yet, despite decades of research, the antib...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-cardiovascularaging-hallmarks...
08/15/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-cardiovascularaging-hallmarksofaging-activity-7362107295645736960-Ikwt?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

🫀 Targeting the Hallmarks of Aging in Cardiovascular Medicine The updated hallmarks of aging framework offers clinicians a blueprint for delaying cardiovascular and systemic decline by intervening in core biological processes. Rather than treating end-stage pathology, we can now match therapies t...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-environmentalhealth-toxicolog...
08/14/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-environmentalhealth-toxicology-activity-7361730947261550593-ow0P?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

Heavy Metals: The Persistent Threat in Our Environment and Biology In precision medicine, one environmental factor is too often underestimated in driving chronic disease and biological aging—heavy metal exposure. The Heliyon review by Briffa et al. highlights how persistent inorganic pollutants in...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_microbiome-longevitymedicine-precisionmedicine-...
08/12/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_microbiome-longevitymedicine-precisionmedicine-activity-7361012630280421377-BZ0d?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

The Gut Microbiome: A Precision Target for Longevity Medicine We’ve entered an era where the gut is no longer just a digestive organ — it’s a central control hub for immune regulation, metabolic balance, cognitive function, and inflammation. Recent research is shifting the paradigm: age-associ...

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-exposomics-preventivemedicine...
08/11/2025

https://www.linkedin.com/posts/anil-bajnath-md-mba-ifmcp-abaarm-61204432_precisionmedicine-exposomics-preventivemedicine-activity-7360658030490710016-cpBs?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAbEwm4BSemaPj3SdyWOHqFgtpRy7BWyGoc

The Exposome: The Missing Link in Precision Prevention and Longevity Medicine Beyond genetics and lifestyle, the exposome—the sum of environmental exposures from conception to death—is emerging as a major driver of chronic disease and aging. This is not about a single toxin, but the complex, cum...

Address

7030 Hi Tech Drive Suite 101
Hanover, MD
21076

Opening Hours

Monday 9am - 5pm
Wednesday 9am - 5pm
Friday 9am - 5pm
Saturday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Anil Bajnath, MD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Anil Bajnath, MD:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

About Dr. Bajnath’s

Dr. Bajnath’s primary field of interest is understanding the underlying causes of unresolved illness and formulating care plans for resolving these complex medical scenarios. He also actively researches pharmacogenomics, nutrigenomics and the microbiome sciences.

Dr. Bajnath completed his undergraduate studies in Molecular-cellular Microbiology (MM) and Medical Laboratory Sciences (MLS) at the University of Central Florida. He graduated medical school with honors from Ross University School of Medicine and additionally was a recipient of a scholarship from Keller School of Business Administration for a Master in Business Administration (MBA) with a focus in Healthcare Services. He completed his residency training with the University of Maryland Department of Family and Community Medicine in January 2019. During his medical school training, Dr. Bajnath assisted and published research with Cleveland Clinic Hospital department of Nephrology. In addition to his conventional training Dr. Bajnath pursued additional training in the field of healing sciences. He completed an extensive seminar series in European Biological Medicine with Paracelsus Clinic of Biological medicine and completed a fellowship and obtained master level instructor status with the Institute for Human Individuality (MIfHI) an organization which professed the concepts of nutrigenomic systems biology and network medicine. He is also a Institute for Functional Medicine Certified Practicioner (IFMCP) and is Board Certified in Anti-Aging and Regenerative Medicine (ABAARM). Additionally, Dr. Bajnath has completed training in integrative medicine which included Clinical Nutrition, Medical Acupuncture, Herbal Medicine, Clinical Homeopathy.

Dr. Bajnath has an extensive history of utilizing complementary alternative medicine techniques to treat his patients. He is a formative expert in helping patients employ prescriptive practices and nutritional modifications based on genomics, exercise and wellness programs into their daily routines in order to better manage their health. In his practice, Dr. Bajnath is committed to formulating an accurate diagnosis and specific care plan for each of his patients. To aid him in this effort, he uses a thorough initial lab evaluation and genomic analysis to quickly uncover the deeper, underlying problems that lead to illness or disease.